Establishing Tomorrow’s
standard of care
Debiopharm
Since its foundation, Debiopharm has been driven by the same commitment: to provide innovative solutions to patients in order to improve their quality of life
Debiopharm was founded in 1979 by Dr. Rolland-Yves Mauvernay. The company is dedicated to in-licensing innovative compounds for development into drugs for commercialization through international partnerships.
Today Debiopharm comprises three companies active in drug development in oncology and bacterial infections (Debiopharm International), drug manufacturing (Debiopharm Research & Manufacturing) and investment in digital health (Debiopharm Innovation Fund).